<html>
<head>
<title>Data Collective and SynBioBeta founder John Cumbers launch a seed stage biotech fund • TechCrunch</title>
<link href="../Styles/Style.css" type="text/css" rel="stylesheet"/>
</head>
<body>
<h1 class="translated">Data Collective 和 SynBioBeta 创始人 John Cumbers 启动种子期生物技术基金 TechCrunch</h1>
<blockquote>原文：<a href="https://web.archive.org/web/https://techcrunch.com/2017/04/04/data-collective-and-synbiobeta-founder-jon-cumbers-create-a-seed-stage-biotech-fund/">https://web.archive.org/web/https://techcrunch.com/2017/04/04/data-collective-and-synbiobeta-founder-jon-cumbers-create-a-seed-stage-biotech-fund/</a></blockquote><div><header class="article__header ">
	<p class="article__title-wrapper">
						</p><h1 class="article__title translated">Data Collective 和 SynBioBeta 创始人 John Cumbers 启动了种子期生物技术基金</h1>
		

			
	
	</header>

			<div class="article-content">
				<p id="speakable-summary"/><div id="attachment_1472294" class="wp-caption alignleft"><a target="_blank" href="https://web.archive.org/web/20221206190522/http://www.dcvc.com/"><img aria-describedby="caption-attachment-1472294" decoding="async" loading="lazy" class="wp-image-1472294 size-medium" src="../Images/002959d0003649400aed68b387699679.png" alt="" srcset="https://web.archive.org/web/20221206190522im_/https://techcrunch.com/wp-content/uploads/2017/04/unnamed.jpg 500w, https://web.archive.org/web/20221206190522im_/https://techcrunch.com/wp-content/uploads/2017/04/unnamed.jpg?resize=150,150 150w, https://web.archive.org/web/20221206190522im_/https://techcrunch.com/wp-content/uploads/2017/04/unnamed.jpg?resize=300,300 300w, https://web.archive.org/web/20221206190522im_/https://techcrunch.com/wp-content/uploads/2017/04/unnamed.jpg?resize=32,32 32w, https://web.archive.org/web/20221206190522im_/https://techcrunch.com/wp-content/uploads/2017/04/unnamed.jpg?resize=50,50 50w, https://web.archive.org/web/20221206190522im_/https://techcrunch.com/wp-content/uploads/2017/04/unnamed.jpg?resize=64,64 64w, https://web.archive.org/web/20221206190522im_/https://techcrunch.com/wp-content/uploads/2017/04/unnamed.jpg?resize=96,96 96w, https://web.archive.org/web/20221206190522im_/https://techcrunch.com/wp-content/uploads/2017/04/unnamed.jpg?resize=128,128 128w" sizes="(max-width: 300px) 100vw, 300px" data-original-src="https://web.archive.org/web/20221206190522im_/https://beta.techcrunch.com/wp-content/uploads/2017/04/unnamed.jpg?w=300"/></a><p id="caption-attachment-1472294" class="wp-caption-text translated">约翰·坎伯斯博士，SynBioBeta 的创始人</p></div>
<p class="translated"><a target="_blank" href="https://web.archive.org/web/20221206190522/http://www.dcvc.com/"> Data Collective (DCVC) </a>带来了约翰·坎伯斯博士，他是合成生物学平台<a target="_blank" href="https://web.archive.org/web/20221206190522/https://synbiobeta.com/"> SynBioBeta </a>的<a target="_blank" href="https://web.archive.org/web/20221206190522/https://synbiobeta.com/person/john-cumbers/">创始人</a>，并为种子前期和种子阶段的初创公司设立了他自己的生物技术基金，被恰当地称为 DCVC SynBioBeta 基金。</p>
<p class="translated">DCVC 的联合管理合伙人马特·奥科(Matt Ocko)向 TechCrunch 介绍了新的发展，他没有为新基金留出确切的数字，但提到 Cumbers 将能够做 15-20 笔相对严肃的交易，从 5 万美元到几百万美元不等。</p>
<p class="translated">根据 Ocko 的说法，DCVC 已经在健康和合成生物学领域进行了大量投资，但现在是时候建立一个官方渠道了。</p>
<p class="translated">“约翰一直在经营合成生物学行业的首要网络，在大多数人之前看到新的公司和技术，并了解技术的发展方向，”Ocko 说。"我们不想让传统的基金结构束缚住约翰的手脚。"</p>
<p class="translated">Ocko 将其与 Accel 的大数据基金进行了比较，但人们可能会将其与 SOS Ventures 及其独立的 IndiBio 基金进行更密切的比较。不过，该基金运作方式更像是一个 Y Combinator，在一个加速器项目中，每家初创企业都有一笔固定金额。相比之下，如果新基金发现下一个 Illumina 或另一种将彻底改变行业的生物技术，DCVC SynBioBeta 将能够创造小额交易，有机会引入更大的 DCVC，增加国库。</p>
<p class="translated">与此同时，合生元仍将一如既往地运行下去，而 DCVC 将获得康伯在该领域多年知识的优势。</p>
<p class="translated">“正如 DCVC 通过我们应用人工智能投资的重要组合所观察到的那样，在合成生物学领域也是如此，一代创业公司的每一次进步都会推动下一代的指数级进步。我们很高兴有约翰帮助我们和我们的企业家把握这个巨大的机会，”DCVC 的另一位管理合伙人扎卡里·博格补充说。</p>
			</div>

			</div>    
</body>
</html>